Arcutis BiotherapeuticsARQT
13F holders, Q2 2024 (June 30)186holders +18
43new positions
29sold out
4famous investors
$9.30avg. 13F price*
At the end of Q2 2024, 186 institutions reported holding Arcutis Biotherapeutics Inc. (ARQT) in their 13F filings, up 18 from Q1 2024. 43 opened new positions and 29 sold out. The largest holders were Jennison Associates LLC ($107.6M), Montanova Capital, LLC ($93.0M) and Rubric Capital Management LP ($91.3M). 4 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Arcutis Biotherapeutics Inc.
- CUSIP
- 03969K108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 43 | $43.2M |
| Exits | 29 | $43.0M |
All 13F filers, Q1 2024 → Q2 2024: 19,998,176 shares bought and 18,721,093 shares sold, net +1,277,083 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 186 holders
| Jennison Associates LLC | 0.07% | Reduce -5.0% | 11,571,694 | $107.6M |
| Montanova Capital, LLC | 3.80% | Add +27.0% | 10,004,492 | $93.0M |
| Rubric Capital Management LP | 2.41% | Add +30.7% | 9,816,672 | $91.3M |
| Frazier Life Sciences Management, L.P. | 3.83% | No change | 8,785,284 | $81.7M |
| BlackRock Inc. | 0.00% | Add +29.5% | 8,622,618 | $80.2M |
| Polar Capital Holdings Plc | 0.38% | Reduce -0.1% | 6,879,072 | $64.0M |
| Vanguard Group Inc. | 0.00% | Add +18.9% | 6,144,290 | $57.1M |
| State Street Corp. | 0.00% | Reduce -41.5% | 5,134,843 | $47.8M |
| Franklin Resources Inc. | 0.01% | Reduce -4.4% | 4,438,179 | $41.3M |
| Morgan Stanley | 0.00% | Reduce -0.8% | 3,972,694 | $36.9M |
| Gilder Gagnon Howe & Co. LLC | 0.42% | Reduce -14.6% | 3,616,532 | $33.6M |
| Citadel Advisors | 0.03% | Add +53.2% | 2,932,647 | $27.3M |
| Cormorant Asset Management, LP | 1.37% | Add +18.8% | 2,525,000 | $23.5M |
| Geode Capital Management, LLC | 0.00% | Add +22.8% | 2,421,270 | $22.5M |
| Ensign Peak Advisors, Inc | 0.04% | Reduce -28.4% | 2,133,702 | $19.8M |
| Pivotal bioVenture Partners Investment Advisor LLC | 14.59% | Add +0.7% | 2,041,108 | $19.0M |
| Deutsche Bank AG | 0.01% | Add +0.5% | 1,882,025 | $17.5M |
| GW&K Investment Management, LLC | 0.14% | Reduce -3.1% | 1,667,979 | $15.5M |
| Perceptive Advisors LLC | 0.35% | Add +107.8% | 1,558,500 | $14.5M |
| Tejara Capital Ltd | 4.55% | Add +42.9% | 1,343,609 | $12.5M |
| J. Goldman & Co LP | 0.45% | Reduce -8.6% | 1,311,549 | $12.2M |
| Candriam S.C.A. | 0.07% | New | 1,307,481 | $12.2M |
| JPMorgan Chase & Co. | 0.00% | Add +28.5% | 1,285,078 | $12.0M |
| American Century Companies Inc. | 0.01% | Add +18.3% | 1,231,700 | $11.5M |
| ExodusPoint Capital Management, LP | 0.11% | Add +401.1% | 1,113,582 | $10.4M |
| Bain Capital Life Sciences Investors, LLC | 1.05% | Reduce -48.8% | 1,030,703 | $9.6M |
| D. E. Shaw & Co. | 0.01% | Add +364.5% | 1,007,384 | $9.4M |
| Stempoint Capital LP | 2.64% | Reduce -56.2% | 965,392 | $9.0M |
| Invesco Ltd. | 0.00% | Add +7.5% | 937,594 | $8.7M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +13.4% | 851,324 | $7.9M |
| Eversept Partners, LP | 0.60% | New | 837,847 | $7.8M |
| Goldman Sachs Group Inc. | 0.00% | Add +0.1% | 807,334 | $7.5M |
| Two Seas Capital LP | 1.20% | Reduce -5.8% | 762,190 | $7.1M |
| Northern Trust Corp. | 0.00% | Add +0.4% | 751,850 | $7.0M |
| Nuveen Asset Management, LLC | 0.00% | Add +196.2% | 735,042 | $6.8M |
| Trexquant Investment LP | 0.09% | Add +83.9% | 667,259 | $6.2M |
| Two Sigma Investments, LP | 0.01% | Add +31.1% | 634,441 | $5.9M |
| Prudential Financial Inc. | 0.01% | Reduce -20.8% | 572,615 | $5.3M |
| Bank of America Corp. | 0.00% | Reduce -33.3% | 567,123 | $5.3M |
| Voloridge Investment Management, LLC | 0.02% | Reduce -40.3% | 563,171 | $5.2M |
| Millennium Management | 0.00% | Add +35.3% | 512,696 | $4.8M |
| Ikarian Capital, LLC | 1.42% | Reduce -17.0% | 489,642 | $4.6M |
| Two Sigma Advisers, LP | 0.01% | Add +47.7% | 488,600 | $4.5M |
| Balyasny Asset Management L.P. | 0.01% | Reduce -44.0% | 437,362 | $4.1M |
| Bank of New York Mellon Corp | 0.00% | Add +25.8% | 390,202 | $3.6M |
| Lazard Asset Management LLC | 0.00% | New | 359,997 | $3.3M |
| Federated Hermes, Inc. | 0.01% | No change | 350,114 | $3.3M |
| Fishman Jay A Ltd. | 0.34% | Add +54.5% | 346,600 | $3.2M |
| PDT Partners, LLC | 0.28% | Reduce -0.2% | 319,715 | $3.0M |
| UBS Group AG | 0.00% | Reduce -36.9% | 309,571 | $2.9M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | New | 273,779 | $2.5M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -68.5% | 259,478 | $2.4M |
| AQR Capital Management | 0.00% | Add +727.5% | 257,357 | $2.4M |
| Schroder Investment Management Group | 0.00% | Add +1122.5% | 221,697 | $2.1M |
| Swiss National Bank | 0.00% | New | 203,600 | $1.9M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 200,000 | $1.9M |
| Jacobs Levy Equity Management, Inc. | 0.01% | New | 175,909 | $1.6M |
| Norges Bank | 0.00% | No change | 174,820 | $1.6M |
| Pennant Investors, LP | 0.43% | No change | 170,900 | $1.6M |
| Rhumbline Advisers | 0.00% | Add +33.5% | 167,289 | $1.6M |
| Ami Asset Management Corp. | 0.08% | Reduce -52.4% | 164,194 | $1.5M |
| Essex Investment Management Co. LLC | 0.28% | New | 163,561 | $1.5M |
| Acadian Asset Management LLC | 0.00% | New | 160,028 | $1.5M |
| Sio Capital Management, LLC | 0.56% | Reduce -74.9% | 159,626 | $1.5M |
| Jump Financial, LLC | 0.03% | Add +124.0% | 151,385 | $1.4M |
| Jane Street Group, LLC | 0.00% | Reduce -29.7% | 150,105 | $1.4M |
| LPL Financial LLC | 0.00% | Reduce -5.5% | 149,540 | $1.4M |
| Aberdeen Group plc | 0.00% | No change | 148,874 | $1.4M |
| DekaBank Deutsche Girozentrale | 0.00% | No change | 140,000 | $1.3M |
| Boothbay Fund Management, LLC | 0.05% | Reduce -17.0% | 142,661 | $1.3M |
| FMR LLC | 0.00% | Reduce -3.4% | 136,335 | $1.3M |
| Los Angeles Capital Management LLC | 0.00% | Reduce -8.4% | 135,948 | $1.3M |
| J. Safra Sarasin Holding AG | 0.02% | — | 129,560 | $1.2M |
| Alliancebernstein L.P. | 0.00% | Add +48.8% | 111,160 | $1.0M |
| Legal & General Group Plc | 0.00% | Add +1155.3% | 104,391 | $971K |
| Barclays PLC | 0.00% | Add +3.7% | 102,113 | $950K |
| California State Teachers Retirement System | 0.00% | Add +1173.3% | 101,302 | $942K |
| State of Wisconsin Investment Board | 0.00% | New | 101,289 | $942K |
| SG Americas Securities, LLC | 0.01% | Add +531.2% | 99,161 | $922K |
| Brevan Howard Capital Management LP | 0.06% | New | 87,830 | $817K |
| Ameriprise Financial Inc. | 0.00% | Reduce -17.6% | 77,406 | $720K |
| MYDA Advisors LLC | 0.21% | No change | 75,000 | $698K |
| Focus Partners Wealth | 0.00% | No change | 63,100 | $680K |
| PEAK6 Investments LLC | 0.03% | Add +133.3% | 70,000 | $651K |
| Graham Capital Management, L.P. | 0.04% | Add +391.4% | 66,165 | $615K |
| Capital Impact Advisors, LLC | 1.71% | New | 65,147 | $606K |
| TrinityBridge Ltd | 0.02% | New | 64,774 | $602K |
| Campbell & CO Investment Adviser LLC | 0.05% | New | 63,093 | $587K |
| MetLife Investment Management, LLC | 0.00% | Add +40.8% | 61,658 | $573K |
| T. Rowe Price Associates Inc. | 0.00% | Add +23.4% | 58,902 | $548K |
| Corebridge Financial, Inc. | 0.00% | — | 57,156 | $532K |
| Legato Capital Management LLC | 0.07% | New | 56,208 | $523K |
| Susquehanna International Group, LLP | 0.00% | Reduce -45.4% | 54,683 | $509K |
| Citigroup Inc. | 0.00% | Reduce -92.4% | 54,599 | $508K |
| Janus Henderson Group PLC | 0.00% | New | 52,600 | $489K |
| Alpha DNA Investment Management LLC | 0.28% | New | 52,244 | $486K |
| Wellington Management Group LLP | 0.00% | Add +12.2% | 52,226 | $486K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 50,444 | $470K |
| Parallax Volatility Advisers, L.P. | 0.01% | Reduce -8.1% | 49,197 | $458K |
| Hennion & Walsh Asset Management, Inc. | 0.02% | Reduce -0.8% | 48,586 | $452K |
"% of holder's portfolio" is ARQT's weight in each manager's 13F, not the share of Arcutis Biotherapeutics Inc. the manager owns.